Clinical trial
Intravitreal Bevacizumab for Retinal Disorders
NCT00403026 · Narayana Nethralaya, Other · Unknown status
Key facts
| NCT number | NCT00403026 |
|---|---|
| Title | Intravitreal Bevacizumab for Retinal Disorders |
| Official title | Off-Label,Intravitreal Use of Bevacizumab for Retinal Disorders |
| Lead sponsor | Narayana Nethralaya, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Wet AMD, Macular Oedema, Proliferative Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | Bevacizumab ( Avastin) |
| Enrollment | 150 |
| Start date | Aug 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 23, 2006 |
| Last update posted | Nov 23, 2006 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: